Steel Partners offers to acquire InMode at $16.75 per share cash deal; stock rises premarket

Steel Partners has launched a formal acquisition offer for InMode (INMD) at $16.75 per share in cash, representing a 20% premium to prior market valuation. This bid signals confidence in InMode's underlying asset value despite recent market skepticism, injecting M&A momentum into the medical aesthetics technology subsector and creating immediate upside for shareholders.

The 20% premium carries dual implications: it validates InMode's operational fundamentals and revenue trajectory in minimally invasive aesthetic devices, yet simultaneously raises questions about whether the bidding price reflects fair value or signals acquirer overconfidence. Steel Partners' cash-based structure eliminates financing risk and suggests conviction in deal completion, reducing arbitrage spread volatility typical of stock-or-cash blended offers.

Governance scrutiny emerges around whether InMode's board pursued adequate strategic alternatives and whether the premium adequately compensates shareholders for forgone upside in an industry experiencing secular tailwinds from cosmetic procedure demand. The acquisition structure also impacts Steel Partners' leverage metrics and return profile, particularly relevant given current debt-market conditions.

Sector implication: The deal signals sustained M&A appetite in health care technology subsectors with recurring revenue models and favorable demographic demand drivers. Validates consolidation thesis for mid-cap medtech and aesthetic device players lacking scale to compete independently in distribution and R&D.